SAN DIEGO, April 9 /PRNewswire-FirstCall/ -- CardioDynamics (Nasdaq: CDIC), the innovator and leader of Impedance Cardiography (ICG) technology, today reported financial results for fiscal first quarter 2009.
Financial Highlights of First Quarter 2009 Compared with First Quarter 2008
- Net sales of $5.1 million, a 12% decrease from $5.8 million, but a 3% increase excluding large Eastern European hospital group sales in the first quarters of 2008 and 2009
- ICG sensor revenue increased 12% to $1.7 million, representing 33% of net sales, up from $1.5 million, or 26% of sales
- Gross margin as a percentage of net sales improved from 69% to 73%
- Reduced operating expenses by 2% to $4.8 million
- Operating loss was $1.0 million, which included $202,000 of non-cash charges for depreciation, amortization and equity compensation
- Net loss from continuing operations of $1.5 million ($0.20 per share loss), down 10% from $1.6 million ($0.23 per share loss)
Additional Key Operating Metrics for the First Quarter of 2009
- BioZ(R) system sales grew 12% to 76 units, compared to 68 units
- ICG device sales totaled 158 units bringing the cumulative total sold to over 8,900 ICG monitors and modules, up 11% from 8,000 one year ago
- U.S. direct sales grew 19% to $3.9 million, up from $3.3 million
- Field headcount averaged 72 field associates, up from 70 one year ago
- Investors retained $5.25 million investment in Company's 8% convertible notes
First Quarter 2009 Operating Results Discussion
The Company reporte
'/>"/>
SOURCE CardioDynamics Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 Related medicine news :1.
CardioDynamics Reports Eighth Consecutive Quarterly Revenue Increase Over Prior Year and 12% Revenue Growth in 20082.
CardioDynamics Announces Investors Retain $5.25 Million 8% Convertible Debt Securities3.
CardioDynamics Reports Second Fiscal Quarter 2008 Results, 18% Revenue Increase for First Half 20084.
CardioDynamics Announces Second Quarter 2008 Conference Call and Webcast5.
CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting6.
CardioDynamics Reports 22% Revenue Growth in First Quarter 20087.
CardioDynamics Board of Directors Proposes Reverse Split 1:7 of Companys Shares8.
CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 20079.
CardioDynamics Announces Strategic Alliance With Leading Medical Equipment Manufacturer in India10.
CardioDynamics Announces Third Quarter 2007 Conference Call and Webcast11.
Streamline Health Solutions, Inc. Reports Fourth Quarter Results